Tempus AI (TEM) Has a $75 Goldman Sachs Target, But Its Data Business Faces a Bigger Test
Goldman Sachs’ Neutral initiation of Tempus AI, Inc.
Tempus Ai Inc. (TEM)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 10,022,634 | $580,611,200 | +5% | 3.77% |
| 2. | SOFTBANK GROUP CORP Masayoshi Son | 5,405,406 | $313,135,170 | 1.72% | |
| 3. | Citadel Investment Group Ken Griffin | 2,512,401 | $145,543,390 | +318% | 0.02% |
| 4. | 1,714,300 | $99,309,399 | -11% | 0.01% | |
| 5. | 1,423,800 | $82,480,734 | +68% | 0.04% |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $81.09 | 645 | $52,303.05 | 809,631 | 2026-09-17 | Filing | |
| $80.52 | 6,855 | $551,964.60 | 810,276 | 2026-09-17 | Filing | |
| $81.09 | 11,609 | $941,373.81 | 14,985,469 | 2026-09-17 | Filing | |
| $80.52 | 123,391 | $9,935,443.32 | 14,997,078 | 2026-09-17 | Filing | |
| $81.09 | 4,942 | $400,746.78 | 8,602,783 | 2026-09-17 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,291,053 | $480,300,706 | 0.01% | |
| 2. | 8,190,133 | $474,454,405 | 0.43% | |
| 3. | 5,336,400 | $309,137,652 | 0.02% | |
| 4. | 4,989,062 | $291,224,842 | 0.02% | |
| 5. | 4,988,038 | $288,957,041 | 0.01% |
News See All
Cathie Wood Sells Tech Favorites Palantir and AMD; Buys Archer Aviation Stock for ARK Innovation ETF
Cathie Wood and her team at ARK Invest made a notable move in their latest portfolio updates. The investment firm sold off shares of tech favorites...
Tempus AI (TEM) Is Building a Heart Failure Agent That Never Sleeps
On September 9, Tempus AI (NASDAQ:TEM) said ARPA-H, a US health research agency, picked it to build an AI that treats heart failure patients without a clinician stepping in.
Tempus AI Stock (TEM) Surges 40% in a Week — Is More Upside Ahead?
Shares of Tempus AI ($TEM) jumped 15% Thursday, extending their five-day gain to nearly 40%. The rally came after CEO Eric Lefkofsky outlined the c...
Cathie Wood Sells $28.6M of Alphabet Stock and Buys $26.4M of Meta Shares. What Else Is She Buying?
Cathie Wood’s ARK Invest bought 43,091 shares of Meta Platforms ($META) worth about $26.4 million on Wednesday, September 9. The firm also added ab...
Cathie Wood Buys $3.6M of HOOD, Sells $2.9M of 2 High-Growth Stocks – September 5
Cathie Wood-led ARK Invest made several notable trades on Friday, September 4, with Robinhood Markets ($HOOD), an online brokerage and financial-se...
Tempus AI Got an $80 Target and 28% Upside Call. Is Wall Street Underestimating Its Healthcare Data Moat?
Tempus AI received a fresh vote of confidence on September 2 as Cantor Fitzgerald initiated coverage with an Overweight rating and an $80 price target.
Cathie Wood Bets $38M on Block Stock, Adds $13M in Rocket Lab Shares
According to Cathie Wood-led ARK Invest’s daily fund disclosures, the firm invested more than $50 million in fintech company Block ($XYZ) and ...
Tempus AI (TEM) Jumped on Moderna’s Melanoma Win. Did its $1.5B Personalis Acquisition Just Get Validated?
Tempus AI, Inc. (NASDAQ:TEM) rallied following a melanoma breakthrough reported by Moderna and Merck.
‘Prepare for What’s Coming,’ Says Investor About Tempus AI Stock
Tempus AI (NASDAQ:TEM) stock is soaring about 22% on Wednesday, with Moderna’s huge melanoma win giving investors a new reason to reconsider the va...